At a $1,008M market cap with a Forward P/E of 47.6, the market is pricing in aggressive forward improvement despite an EPS of -10.5, negative operating margin of -23.00%, and ROIC of -15.90%. The Altman Z-Score of 1 signals financial distress risk, while a current ratio of 0.1 underscores acute liquidity pressure. Return on Equity at 50.60% looks optically strong, but against deeply negative earnings and thin liquidity, it likely reflects capital structure distortion rather than durable profitability. This is not a mispriced compounder—it is a speculative turnaround trading at a growth multiple while balance sheet risk remains elevated.